T1	value 1020 1028	4.3-fold
T2	food 1063 1079	grapefruit juice
T3	dosage 1099 1108	one glass
T4	frequency 11 30	regular consumption
T5	food 1112 1128	grapefruit juice
T6	pharmacokinetics 113 133	substrate for CYP3A4
T7	frequency 1136 1141	daily
T8	interaction 1156 1165	increases
T9	pharmacokinetics 1170 1191	plasma concentrations
T10	drug 1195 1206	simvastatin
T11	drug 1211 1227	simvastatin acid
T12	food 1229 1245	Grapefruit juice
T13	interaction 1250 1258	increase
T14	drugEffect 1268 1295	cholesterol-lowering effect
T15	parameter 1268 1279	cholesterol
T16	enzyme 127 132	CYP3A
T17	pathology 1312 1327	adverse effects
T18	drug 1331 1342	simvastatin
T19	pharmacokinetics 138 161	extensively metabolized
T20	pharmacokinetics 173 183	first pass
T21	frequency 226 245	regular consumption
T22	food 249 265	grapefruit juice
T23	pharmacokinetics 273 289	pharmacokinetics
T24	drug 293 304	simvastatin
T25	studyType 320 363	randomized cross-over study with two phases
T26	food 34 50	grapefruit juice
T27	population 365 386	10 healthy volunteers
T28	mode 387 395	ingested
T29	food 396 412	grapefruit juice
T30	dosage 413 419	200 ml
T31	food 423 428	water
T32	duration 439 449	for 3 days
T33	dosage 463 475	single 40-mg
T34	drug 484 495	simvastatin
T35	mealTime 513 517	with
T36	food 518 534	grapefruit juice
T37	dosage 535 541	200 ml
T38	food 545 550	water
T39	pharmacokinetics 552 573	Plasma concentrations
T40	drug 577 588	simvastatin
T41	pharmacokinetics 58 74	pharmacokinetics
T42	drug 593 609	simvastatin acid
T43	food 647 663	Grapefruit juice
T44	interaction 664 673	increased
T45	pharmacokinetics 678 692;719 725	area under the curves
T46	pharmacokinetics 742 745	AUC
T47	drug 756 767	simvastatin
T48	value 768 776	3.6-fold
T49	drug 78 89	simvastatin
T50	drug 820 836	simvastatin acid
T51	value 837 845	3.3-fold
T52	pharmacokinetics 896 915	peak concentrations
T53	pharmacokinetics 917 923	C(max)
T54	drug 928 939	simvastatin
T55	drug 944 960	simvastatin acid
T56	interaction 966 975	increased
T57	value 976 984	3.9-fold
T58	drug 98 109	Simvastatin
A1	valence T56 Augmentation
A2	valence T44 Augmentation
A3	valence T13 Augmentation
A4	valence T8 Augmentation
R1	metabolism_decrease Arg1:T43 Arg2:T47	
R2	metabolism_decrease Arg1:T2 Arg2:T55	
R3	metabolism_decrease Arg1:T2 Arg2:T54	
R4	metabolism_decrease Arg1:T5 Arg2:T10	
R5	metabolism_decrease Arg1:T5 Arg2:T11	
R6	physiological_effect_antagonism Arg1:T12 Arg2:T18	
#1	AnnotatorNotes R6	Impact clinique
R7	metabolism_decrease Arg1:T43 Arg2:T50	
